Also listed on Isis Pharmaceuticals, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 1, 2026 · Low confidence
20-year base term ends Dec 1, 2026
Dec 1, 2006
Dec 1, 2026
Oct 29, 2013
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 1, 2006, when application PCT/US2006/046122, the earliest non-provisional in its chain, was filed (this one was filed Jan 5, 2012); a parent in its chain could not be resolved (the next row) | Dec 1, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,114,856) | resolves to Dec 1, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: PCTUS2006046122, PCTUS2006046122, PCTUS2006046122 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Dec 1, 2026 | Low confidence |
This family
| Application PCT/US2006/046122 | PCT application no patent term | no patent term |
| US 7,893,039 | In force Jul 2027 | Jul 2027 |
| US 8,114,856 | In force Dec 2026 | Dec 2026 |
| US 8,569,264 | this patent Dec 2026 | Dec 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 16, 2012 Reel 27880, frame 197 | Swayze, Eric E.; Hanessian, Stephen; Szychowski, Janek; Adhikari, Susanta Sekhar; Pachamuthu, Kandasamy; Wang, Xiaojing; Migawa, Michael T.; Griffey, Richard H. | Isis Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jun 28, 2017 Reel 43029, frame 302 | Isis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | Change of Name |
| Apr 19, 2019 Reel 48947, frame 702 | Achaogen, Inc. | Silicon Valley Bank | Intellectual Property Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,114,856, ends no earlier than this term, so it caps nothing.